
Esovia IV 40mg Injection
Marketer
Limbson Pharmaceuticals LLP
Salt Composition
Esomeprazole (40mg)
Overview Esovia IV 40mg Injection
Intravenous Esovia (40mg) is a medication that lowers gastric acid secretion. It's indicated for treating stomach and intestinal conditions stemming from excess acid, including acid reflux and other related disorders. Esovia IV 40mg also prevents stress ulcers in critically ill patients and is pre-administered before anesthesia to mitigate aspiration risks. Classified as a proton pump inhibitor (PPI), it's administered intravenously by medical professionals only when deemed preferable to oral forms. Dosage and treatment length are determined by individual needs and response. Optimizing treatment involves consuming smaller, more frequent meals and avoiding caffeine, spicy foods, and fatty foods. Common side effects, usually mild, encompass injection site reactions, nausea, headache, dizziness, gas, diarrhea, stomach pain, and fundic gland polyps. Persistent or bothersome symptoms warrant medical attention. Bone loss prevention strategies, such as calcium and vitamin D supplementation, should be discussed with your physician. Esovia IV 40mg is contraindicated for individuals with severe hepatic impairment, those on HIV medications, those with a history of PPI allergy, or pre-existing osteoporosis. Pregnant or lactating individuals must consult their doctor. Alcohol consumption should be avoided due to its potential to increase gastric acid production and exacerbate symptoms.
Uses of Esovia IV 40mg Injection
Managing gastroesophageal reflux disease (GERD)
Major Benefits of Esovia IV 40mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Esovia IV 40mg Injection:
- Injection site reaction
- Headache
- Dizziness
- Dryness in mouth
- Nausea
- Abdominal pain
- Constipation
- Flatulence
- Diarrhea
- Fundic gland polyps
How to use Esovia IV 40mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Esovia IV 40mg Injection works:
Gastric acid production is suppressed by the intravenous administration of 40mg Esovia, a proton pump inhibitor (PPI), thus alleviating heartburn and acid indigestion.
SAFETY ADVICE
AlcoholCAUTION
It is recommended to avoid alcohol while using Esovia IV 40mg Injection. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Esovia IV 40mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to any prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Administering Esovia IV 40mg Injection to breastfeeding individuals carries a likely risk. Available human data indicate potential transfer to breast milk, posing a possible threat to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Esovia IV 40mg Injection on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneyCAUTION
Administering Esovia IV 40mg Injection requires careful consideration in individuals exhibiting severe renal impairment. Dosage modification for Esovia IV 40mg Injection might be necessary. Physician consultation is advised. Dosage alterations are unnecessary for patients with mild or moderate kidney dysfunction.
LiverCAUTION
Administering Esovia IV 40mg Injection requires careful consideration in individuals exhibiting severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alteration is unnecessary for patients with mild or moderate liver dysfunction.
What if you forget to take Esovia IV 40mg Injection :
Omitting a scheduled dose of Esovia IV 40mg Injection necessitates contacting your physician.
Facts to Know About Esovia IV 40mg Injection
| Label | Value |
|---|---|
| Chemical Classification | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Type of Treatment | Gastrointestinal system |
| Action Class | Gastric acid suppressants |
